Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Case report
FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,121 | Dovepress* | 4,830+ | 251 | 5,081 | |
| PubMed Central* | 291 | 71 | 362 | ||
| Totals | 5,121 | 322 | 5,443 | ||
| *Since 10 June 2022 | |||||
View citations on PubMed Central and Google Scholar